Back | Next |
home / stock / jagx / jagx message board
Subject | By | Source | When |
---|---|---|---|
The chart won't tell you anything anymore after | ShadowDiviner72 | investorshub | 06/06/2024 8:07:23 AM |
Yea that's very obvious by the chart data. | SonicTheHedgeFun | investorshub | 06/05/2024 6:44:45 PM |
No idea, but consistently lower chart over time | Termite7 | investorshub | 06/05/2024 5:26:51 PM |
That's the first gap fill on the monthly | SonicTheHedgeFun | investorshub | 06/05/2024 5:10:33 PM |
FWIW, my sell-point is ~$8ish.......... | Termite7 | investorshub | 06/05/2024 5:04:59 PM |
Interesting moves. | DanDosh | investorshub | 06/05/2024 4:57:09 PM |
So basically I just watched people scoop up | SonicTheHedgeFun | investorshub | 06/05/2024 4:57:08 PM |
Run??? | Termite7 | investorshub | 06/05/2024 4:56:25 PM |
And this is precisely the reason i'm boiling, | DanDosh | investorshub | 06/05/2024 3:00:32 PM |
Not the sellers that are a 'concern', its | timberwolf7 | investorshub | 06/05/2024 2:18:28 PM |
On RISK assessment pre-positiioning, don't get me wrong, | timberwolf7 | investorshub | 06/05/2024 1:46:49 PM |
It's hard to have patience when the stock | DanDosh | investorshub | 06/05/2024 1:40:06 PM |
Actually there is just 1 thing to say. | ShadowDiviner72 | investorshub | 06/05/2024 1:17:54 PM |
While i agree with you in principle, i | DanDosh | investorshub | 06/05/2024 12:57:34 PM |
Actually, its better to be 'cautious' vs 'optimistic' | timberwolf7 | investorshub | 06/05/2024 12:43:57 PM |
Why are you being so stupid? Why would | timberwolf7 | investorshub | 06/05/2024 12:40:59 PM |
The article clearly states that it are 'strategic | DanDosh | investorshub | 06/05/2024 12:07:02 PM |
You are really a weak poster. The article | ShadowDiviner72 | investorshub | 06/05/2024 11:52:02 AM |
Putting Nvidia near jagx and a couple of | DanDosh | investorshub | 06/05/2024 11:40:07 AM |
Would you 'consume' your biggest ever catalyst to | ShadowDiviner72 | investorshub | 06/05/2024 10:45:33 AM |
News, Short Squeeze, Breakout and More Instantly...
Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis; Click here ...
New patents issued for core rare disease target indications for crofelemer Napo has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (...
Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific ...